Related Experiment Video

Updated: Aug 22, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Diabetes, the renin-angiotensin system and heart disease

Hoong Sern Lim1, Gregory Y H Lip

  • 1University Department of Medicine, City Hospital Birmingham, England, UK.

Current Vascular Pharmacology
|August 24, 2004
PubMed

Insights

Cardiovascular disease remains the primary cause of death in diabetes patients, driven by complex mechanisms. This review explores the renin-angiotensin-aldosterone system

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is the leading cause of mortality in patients with diabetes.
  • Diabetes-related heart disease involves complex, overlapping mechanisms including atherosclerosis, microvascular dysfunction, and cardiomyopathy.
  • Hypertension and diabetic nephropathy significantly worsen these cardiac complications.

Purpose of the Study:

  • To review the multifaceted role of the renin-angiotensin-aldosterone system (RAAS) in diabetes-related heart disease.
  • To elucidate the pathophysiological mechanisms underlying diabetes-related cardiac complications.
  • To examine emerging evidence for RAAS inhibition in managing diabetes-related heart disease.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • Focuses on the pathophysiological mechanisms of diabetes-related heart disease.
  • Examines the role of the renin-angiotensin-aldosterone system.

Main Results:

  • The renin-angiotensin-aldosterone system plays a central role in driving the pathophysiology of diabetes-related heart disease.
  • Diabetes accelerates atherosclerosis, impairs microvasculature, and causes intrinsic myocardial dysfunction.
  • These effects are compounded by hypertension and diabetic nephropathy.

Conclusions:

  • The renin-angiotensin-aldosterone system is a key therapeutic target in diabetes-related heart disease.
  • Further research into specific RAAS inhibition strategies is warranted.
  • Comprehensive management strategies are needed for diabetic cardiovascular complications.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...